172 related articles for article (PubMed ID: 10614547)
1. Correlation among markers of renal osteodystrophy in pediatric hemodialysis patients.
Piscitelli J; Cabansag MR; Silverstein DM
J Pediatr Endocrinol Metab; 1999; 12(6):879-86. PubMed ID: 10614547
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
[TBL] [Abstract][Full Text] [Related]
3. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
[TBL] [Abstract][Full Text] [Related]
4. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
Coen G; Mazzaferro S; Ballanti P; Bonucci E
J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
[No Abstract] [Full Text] [Related]
5. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
6. [Determination of bone mineral content and correlations with calciotropic hormones in periodic hemodialysis patients].
Anelli F; De Maio P; Girardi V; Papagni S; Rossi G; Cantatore FP; Carrozzo M
Minerva Urol Nefrol; 1992; 44(4):265-73. PubMed ID: 1299008
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
[TBL] [Abstract][Full Text] [Related]
8. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure].
Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Nahaczewska W
Pol Merkur Lekarski; 2002 Apr; 12(70):257-60. PubMed ID: 12089882
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
[TBL] [Abstract][Full Text] [Related]
11. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis.
Laster M; Soohoo M; Streja E; Elashoff R; Jernigan S; Langman CB; Norris KC; Salusky IB; Kalantar-Zadeh K
Pediatr Nephrol; 2019 Jan; 34(1):107-115. PubMed ID: 30267239
[TBL] [Abstract][Full Text] [Related]
12. Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy.
Mazzaferro S; Coen G; Ballanti P; Bondatti F; Bonucci E; Pasquali M; Sardella D; Tomei E; Taggi F
Nephron; 1990; 56(3):261-6. PubMed ID: 2077408
[TBL] [Abstract][Full Text] [Related]
13. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.
Gal-Moscovici A; Popovtzer MM
Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-6 in renal osteodystrophy: relationship with serum PTH and bone remodeling markers.
Montalbán C; García-Unzueta MT; De Francisco AL; Amado JA
Horm Metab Res; 1999 Jan; 31(1):14-7. PubMed ID: 10077343
[TBL] [Abstract][Full Text] [Related]
16. A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients.
Kurata S; Ishibashi M; Nishida H; Hiromatsu Y; Hayabuchi N
Ann Nucl Med; 2004 Sep; 18(6):513-8. PubMed ID: 15515752
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.
Mazzaferro S; Chicca S; Pasquali M; Zaraca F; Ballanti P; Taggi F; Coen G; Cinotti GA; Carboni M
Nephrol Dial Transplant; 2000 Jun; 15(6):877-82. PubMed ID: 10831645
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
Salusky IB; Ramirez JA; Oppenheim W; Gales B; Segre GV; Goodman WG
Kidney Int; 1994 Jan; 45(1):253-8. PubMed ID: 8127016
[TBL] [Abstract][Full Text] [Related]
19. Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry.
Charhon SA; Delmas PD; Malaval L; Chavassieux PM; Arlot M; Chapuy MC; Meunier PJ
J Clin Endocrinol Metab; 1986 Oct; 63(4):892-7. PubMed ID: 3488998
[TBL] [Abstract][Full Text] [Related]
20. [Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients].
Bednarek-Skublewska A; Chrapko B; Ksiazek A
Pol Arch Med Wewn; 2003 Sep; 110(3):943-50. PubMed ID: 14699686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
